In addition to activating SREBP1, MYC directly regulates the expression of key enzymes involved in FA synthesis, such as ACLY, ACC, FASN, and SCD1, which have been shown to drive tumorigenesis in hepatocellular carcinoma (HCC) [83–85]. This evidence concerns the gene ACLY and hepatocellular carcinoma.